IMKTA's 1‑year return of +51.1%—more than double the S&P's +27.4%—signals a powerful compounding effect, driven by sustained earnings growth and share‑price upgrades, making it a standout outlier in the consumer‑grocery niche.
While historical outperformance is strong, the stock's reliance on regional market concentration exposes it to localized economic downturns; a 5% dip in North Carolina disposable income could erode earnings by roughly 2%, potentially compressing the long‑term annualized return to below 6%.
Despite strong institutional accumulation, the 4.35% increase is modest compared to peers that have seen double‑digit inflows; if larger funds shift capital toward higher‑growth retailers, IMKTA could face relative underperformance as smart money seeks faster earnings acceleration.
Revenue contraction of over 5% YoY is the most striking growth issue, as it not only erodes market share but also pressures earnings per share, undermining the company’s ability to fund future expansion without external capital.
The net margin of only 1.6% translates to $84 M of profit on a $5.3 B revenue base; a 0.5‑percentage‑point decline would cut earnings by roughly $26 M, intensifying the risk that modest sales downturns could push the company into operating losses.
The most striking finding is the equity multiplier’s collapse to 1.59x, which eliminated nearly half of the previous ROE boost from leverage and signals a strategic shift toward a more conservative capital structure that may appeal to risk‑averse investors but dampens earnings growth potential.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 5.2 | 1.6 | 2.08 | 1.59 | 5.3 | 5.2 | 3.3 |
| 2024 | 6.8 | 1.9 | 2.23 | 1.64 | 6.8 | 6.7 | 4.2 |
| 2023 | 14.4 | 3.6 | 2.38 | 1.70 | 14.0 | 13.6 | 8.5 |
| 2022 | 21.7 | 4.8 | 2.47 | 1.82 | 19.7 | 19.2 | 11.9 |
| 2021 | 25.4 | 5.0 | 2.47 | 2.05 | 20.8 | 20.4 | 12.4 |
| 2020 | 21.8 | 3.9 | 2.43 | 2.32 | 18.2 | 17.8 | 9.4 |
| 2019 | 12.3 | 1.9 | 2.25 | 2.82 | 9.5 | 9.4 | 4.4 |
| 2018 | 16.4 | 2.4 | 2.24 | 3.06 | 8.1 | 8.0 | 5.3 |
| 2017 | 10.5 | 1.3 | 2.31 | 3.39 | 8.7 | 8.6 | 3.1 |
| 2016 | 11.5 | 1.4 | 2.25 | 3.59 | 9.0 | 8.9 | 3.2 |
| 2015 | 13.8 | 1.6 | 2.28 | 3.86 | 10.1 | 9.9 | 3.6 |
A key risk is the thin ROIC spread of only ~0.5% over cost of capital; any slowdown in sales growth or increase in operating expenses could push ROIC below the hurdle rate, eroding shareholder value and limiting funds available for store upgrades or acquisitions.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 176 | 43 | 7 | 105 | 16 | 35 |
| 2024 | 164 | 39 | 5 | 101 | 17 | 27 |
| 2023 | 153 | 40 | 7 | 91 | 17 | 30 |
| 2022 | 148 | 39 | 6 | 91 | 18 | 27 |
| 2021 | 148 | 39 | 7 | 103 | 19 | 27 |
| 2020 | 150 | 39 | 6 | 111 | 22 | 24 |
| 2019 | 162 | 43 | 6 | 117 | 17 | 32 |
| 2018 | 163 | 44 | 6 | 116 | 19 | 31 |
| 2017 | 158 | 42 | 6 | 115 | 18 | 30 |
| 2016 | 162 | 44 | 6 | 120 | 20 | 30 |
| 2015 | 160 | 43 | 6 | 117 | 21 | 28 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $2566M | $950M | $1616M | $544M | $177M | $366M | $976M | $303M |
| 2024 | $2528M | $982M | $1546M | $565M | $211M | $354M | $926M | $321M |
| 2023 | $2474M | $1015M | $1459M | $595M | $267M | $329M | $953M | $331M |
| 2022 | $2296M | $1036M | $1260M | $613M | $345M | $267M | $838M | $334M |
| 2021 | $2018M | $1035M | $983M | $632M | $562M | $70M | $575M | $306M |
| 2020 | $1899M | $1080M | $819M | $655M | $648M | $7M | $470M | $324M |
| 2019 | $1867M | $1205M | $663M | $852M | $810M | $42M | $497M | $248M |
| 2018 | $1825M | $1229M | $595M | $866M | $855M | $11M | $497M | $260M |
| 2017 | $1733M | $1222M | $511M | $878M | $854M | $24M | $446M | $246M |
| 2016 | $1686M | $1216M | $470M | $876M | $871M | $6M | $418M | $242M |
| 2015 | $1655M | $1226M | $429M | $886M | $879M | $8M | $424M | $252M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $154M | $-110M | $-32M | $-115M | $40M | $-12M | |
| 2024 | $263M | $-206M | $-31M | $-211M | $52M | $-12M | |
| 2023 | $266M | $-170M | $-35M | $-174M | $93M | $-12M | |
| 2022 | $339M | $-112M | $-31M | $-120M | $220M | $-12M | |
| 2021 | $306M | $-128M | $-115M | $-141M | $166M | $-80M | $-13M |
| 2020 | $350M | $-117M | $-268M | $-123M | $227M | $-13M | |
| 2019 | $212M | $-153M | $-27M | $-162M | $50M | $-13M | |
| 2018 | $161M | $-148M | $-26M | $-150M | $11M | $-13M | |
| 2017 | $156M | $-125M | $-13M | $-128M | $29M | $-13M | |
| 2016 | $159M | $-137M | $-24M | $-138M | $21M | $-13M | |
| 2015 | $153M | $-100M | $-55M | $-104M | $49M | $-13M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-08 · finexus.net